Скачать или смотреть AI is Changing the Landscape of Cancer Research and Immunotherapy

How will AI transform the future of cancer treatment?
This was the central question guiding a recent Cancer Research Institute (CRI) panel hosted and moderated by CRI CEO Alicia Zhou, PhD. This event brought together leaders in biotech innovation and academic research who are pioneering the use of artificial intelligence (AI) to accelerate collaboration and turn breakthroughs into lifesaving treatments.
· Marc Tessier-Lavigne, PhD, CEO, Xaira Therapeutics
· Alex Marson, MD, PhD, Gladstone Institute, UCSF, CRI Lloyd J. Old STAR
· Ansu Satpathy, MD, PhD, Stanford University, CRI Lloyd J. Old STAR
We uncovered five key insights that demonstrate how AI and the scientists behind it are shaping the next wave of progress in cancer immunotherapy.

Explore the full article: https://www.cancerresearch.org/blog/5...

--
About CRI:
The Cancer Research Institute (CRI) is a nonprofit organization exclusively focused on advancing cancer immunotherapy through rigorous scientific research, global collaboration, and data-driven innovation. Since 1953, CRI has empowered researchers to uncover how the immune system can fight cancer - and helped transform bold scientific ideas into treatments.
Our mission is to create a world immune to cancer by driving scientific discovery, accelerating collaboration, and turning breakthroughs into life-saving treatments. Our work bridges the gap between discovery and patient impact, ensuring that scientific innovation translates into real-world treatments.

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.